Effect of losartan on the ultrastructural morphology of blood cells in patients with diabetes mellitus and hypertension

Ultrastructural changes of blood cells in with patients with hypertension of 1-2-degree, in patients with diabetes mellitus type 2 at compensation and subcompensation phase as well as in patients with diabetes mellitus and hypertension during correction of blood pressure with losartan was defined. I...

Full description

Bibliographic Details
Published in:	Medičnì Perspektivi
Main Authors:	Pertseva N.O., Turlyun T.S.
Format:	Article
Language:	English
Published:	Dnipro State Medical University 2013-06-01
Subjects:	arterial hypertension diabetes mellitus type 2 ultrastructure of platelets and white blood cells losartan
Online Access:	http://medpers.dsma.dp.ua/issues/2013/N2/31-40.pdf

Similar Items

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
by: I. N. Medvedev, et al.
Published: (2008-10-01)

Losartan in postmenopausal women with essential arterial hypertension
by: O. N. Tkacheva, et al.
Published: (2010-12-01)

Comparative effectiveness of original and generic losartan in patients with arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2007-12-01)

Losartan effectiveness in arterial hypertension patients (ELLA study)
by: I. E. Chazova, et al.
Published: (2007-04-01)

Change in endothelial function state under the influence of antihypertensive therapy in patients with arterial hypertension and high cardiovascular risk
by: Turlyun T.S.
Published: (2014-03-01)

Pleiotropic Effects of Losartan in Hypertensive Patients with Dyslipidemia
by: Sivakumar Sivasubramaniam, et al.
Published: (2017-09-01)

Losartan therapy in gout patients
by: A. I. Ilyina, et al.
Published: (2008-04-01)

Losartan therapy and hyperuricemia correction in patients with metabolic syndrome and arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2011-12-01)

Change in endothelial function state under the influence of antihypertensive therapy in patients with arterial hypertension and high cardiovascular risk.
by: T. S. Turlyun
Published: (2014-03-01)

СARDIOPROTECTION IN PATIENTS WITH HYPERTENSION – THE ROLE OF LOSARTAN
by: I. I. Chukaeva, et al.
Published: (2015-09-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
by: Sh. V. Akhadov, et al.
Published: (2011-02-01)

COMPARATIVE EFFECTIVENESS OF PERINDOPRIL AND LOSARTAN IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY
by: S. V. Nedogoda, et al.
Published: (2012-02-01)

Efficacy of a fixed-dose combination (amlodipine/losartan) in the treatment of a patient with arterial hypertension, dyslipidemia and obesity
by: V. P. Mikhin
Published: (2020-01-01)

COMPARATIVE EVALUATION OF THE ANTIHYPERTENSIVE EFFECT OF PERINDOPRIL AND LOSARTAN POTASSIUM IN PATIENTS WITH ARTERIAL HYPERTENSION AND STENOTIC CORONARY ATHEROSCLEROSIS BEFORE REVASCULARIZATION: AN OPEN RANDOMIZED COMPARATIVE STUDY
by: O. A. Osipova, et al.
Published: (2016-01-01)

ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 2-3 DEGREE WITH FIXED COMBINATION OF ENALAPRIL OR LOSARTAN WITH HYDROCHLOROTHIAZIDE
by: A. A. Kudryavtsev, et al.
Published: (2016-01-01)

Does Losartan reduce the severity of COVID-19 in hypertensive patients?
by: Mohammadreza Mirjalili, et al.
Published: (2022-03-01)

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
by: Shuyang Zhang, et al.
Published: (2023-06-01)

Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
by: Goran Kekovic, et al.
Published: (2012-01-01)

Optimizing Blood Pressure Control: A Randomized Comparative Trial of Losartan/Chlorthalidone vs. Losartan/Hydrochlorothiazide
by: Isabel E. Rucker-Joerg, et al.
Published: (2025-04-01)

Efficacy of fixed-dose amlodipine and losartan combination compared with amlodipine monotherapy in stage 2 hypertension: a randomized, double blind, multicenter study
by: Lee Hae-Young, et al.
Published: (2011-10-01)

ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE
by: R. M. Linchak, et al.
Published: (2016-01-01)

Comparison of the GPVI inhibitors losartan and honokiol
by: Marie-Blanche Onselaer, et al.
Published: (2020-02-01)

Effect of Losartan and Atenolol on heart rate variability in newly diagnosed essential hypertensive patient
by: Shamima Sultana, et al.
Published: (2016-08-01)

Antihypertensive and antihyperglycemic effects of combinations of losartan with metformin and/or glibenclamide in desoxycorticosterone acetate and streptozotocin-induced hypertensive diabetic rats
by: Emuesiri Goodies Moke, et al.
Published: (2023-04-01)

A Comparative Study of Tolerability of Losartan versus Atenolol in Essential Hypertension and Their Effect on Lipid Profile
by: Amrutha Torvi, et al.
Published: (2021-12-01)

Effects of losartan combined with exercise training in spontaneously hypertensive rats
by: L.F. Azevedo, et al.
Published: (2003-11-01)

Dynamics of endothelial function violation in patients with arterial hypertension with moderate cardiovascular risk and antihypertensive therapy treatment influence
by: T. S. Turlyun
Published: (2016-08-01)

Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan
by: Antônio Carlos Avanza Jr, et al.
Published: (2000-02-01)

Effect of angiotensin-converting enzyme gene polymorphism at the results of losartan use in the patients with type 2 diabetes mellitus
by: T. Yu. Poniatowskaya
Published: (2015-03-01)

Effect of angiotensin-converting enzyme gene polymorphism at the results of losartan use in the patients with type 2 diabetes mellitus
by: T. Yu. Poniatowskaya
Published: (2015-03-01)

Low-dose combination of losartan, hydrochlorothiazide, and magnetic laser therapy: clinical effectiveness and quality of life impact
by: Kh. Z. Musieva, et al.
Published: (2008-08-01)

Losartan and QT Dispersion in Hypertensive Patients on Maintenance Hemodialysis
by: Alparslan Ersoy, et al.
Published: (2014-12-01)

Determination of Losartan and Losartan Carboxylic acid in Human Plasma by New HPLC Method with Fluorescence Detection for Pharmacokinetics Studies
by: Ahmed Abbas Hussein
Published: (2014-12-01)

The effects of acute administration of losartan, angiotensin II type-1 receptor antagonist, on hemodynamics and oxidative stress parameters in malignant hypertensive rats
by: Bogunović Natalija, et al.
Published: (2015-01-01)

Metabolomic Profile, Plasmatic Levels of Losartan and EXP3174, Blood Pressure Control in Hypertensive Patients and Their Correlation with COVID-19
by: Kamila A. Queiroz, et al.
Published: (2023-09-01)

Influence of arterial hypertension treated with losartan on skin healing in rats
by: Maria de Lourdes Pessole Biondo-Simões, et al.
Published: (2006-06-01)

Influence of losartan on structural and functional remodelling of cardiovascular system in comorbidity of chronic obstructive lung disease and arterial hypertension
by: V. A. Nikitin, et al.
Published: (2016-10-01)

INFLUENCE OF N-ACETYLCYSTEINE AND LOSARTAN ON THE EARLY ELECTROCARDIOGRAPHIC CHANGES IN RATS WITH STREPTOZOTOCIN TYPE 1 DIABETES MELLITUS
by: I. Sytnyk, et al.
Published: (2016-09-01)

DIFFERENCES IN EFFECTIVENESS OF ANTIHYPERTENSIVE THERAPY IN MEN AND WOMEN: LOSARTAN VERSUS ENALAPRIL
by: E. I. Tarlovskaya, et al.
Published: (2016-01-01)

The effects of single and combined application of ramipril and losartan on renal structure and function in hypertensive rats
by: Lin Yun, et al.
Published: (2018-10-01)